Bank Of New York Mellon Corp United Therapeutics Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $119 Million - $162 Million	578,607 New	578,607 $161 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $35.5 Million - $42.6 Million	-174,377 Reduced 22.33%	606,532 $127 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $8.98 Million - $12.4 Million	-51,342 Reduced 6.17%	780,909 $184 Million
Q1 2022 May 11, 2022	SELL	$166.16 - $213.96 $30.2 Million - $38.9 Million	-181,714 Reduced 17.92%	832,251 $149 Million
Q4 2021 Feb 11, 2022	BUY	$184.32 - $216.08 $31.2 Million - $36.5 Million	169,007 Added 20.0%	1,013,965 $219 Million
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $22.2 Million - $26.5 Million	123,295 Added 17.08%	844,958 $156 Million
Q2 2021 Aug 11, 2021	BUY	$170.47 - $211.93 $9.16 Million - $11.4 Million	53,760 Added 8.05%	721,663 $129 Million
Q1 2021 May 13, 2021	BUY	$153.94 - $174.85 $25.5 Million - $28.9 Million	165,383 Added 32.91%	667,903 $112 Million
Q4 2020 Feb 09, 2021	BUY	$101.87 - $151.79 $1.78 Million - $2.65 Million	17,440 Added 3.6%	502,520 $76.3 Million
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $416,483 - $504,990	-4,169 Reduced 0.85%	485,080 $49 Million
Q2 2020 Aug 12, 2020	BUY	$92.74 - $125.82 $1.75 Million - $2.38 Million	18,893 Added 4.02%	489,249 $59.2 Million
Q1 2020 May 06, 2020	SELL	$79.39 - $115.35 $282,549 - $410,530	-3,559 Reduced 0.75%	470,356 $44.6 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $4.24 Million - $5.16 Million	-54,128 Reduced 10.25%	473,915 $41.7 Million
Q3 2019 Nov 07, 2019	SELL	$74.85 - $85.99 $2.21 Million - $2.54 Million	-29,488 Reduced 5.29%	528,043 $42.1 Million
Q2 2019 Aug 12, 2019	SELL	$76.06 - $120.81 $4.67 Million - $7.42 Million	-61,458 Reduced 9.93%	557,531 $43.5 Million
Q1 2019 May 14, 2019	BUY	$107.15 - $126.84 $5.16 Million - $6.1 Million	48,129 Added 8.43%	618,989 $72.6 Million
Q4 2018 Feb 11, 2019	SELL	$101.4 - $128.73 $4.96 Million - $6.29 Million	-48,874 Reduced 7.89%	570,860 $62.2 Million
Q3 2018 Nov 09, 2018	SELL	$113.81 - $129.46 $5.57 Million - $6.33 Million	-48,925 Reduced 7.32%	619,734 $0
Q2 2018 Aug 06, 2018	SELL	$101.14 - $118.31 $4.01 Million - $4.69 Million	-39,680 Reduced 5.6%	668,659 $75.7 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $6.71 Million - $9.51 Million	-62,564 Reduced 8.12%	708,339 $79.6 Million
Q4 2017 Feb 09, 2018	BUY	$118.58 - $151.28 $91.4 Million - $117 Million	770,903	770,903 $114 Million

Others Institutions Holding UTHR

# of Institutions

676

Shares Held

42.1M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$2.03 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.64 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.18 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.06 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$832 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account